A Game-Changer for Breast-Cancer Diagnostics
The Breast Institute of New Zealand is the culmination of Dr. Monica Saini’s vision for a revolutionary private breast clinic. “I wanted to create a centre where we do the highest quality imaging, and can be an education and research platform,” says Dr. Saini, a breast radiologist who trained in her native United States. “We are a place for women to come and learn about themselves.”
Princeton, NJ -- November 27, 2013 -- GE Healthcare today announced results from a new study, which showed that patients receiving Visipaque™ (iodixanol 320mg I/ml) were less likely to experience discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving Isovue® (iopamidol 370 mg I/ml). As with other iodinated contrast agents, Visipaque is often associated with sensations of discomfort, heat or pain. The data were published online in Acta Radiologica.[i]
business unit
tags
MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."
Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.
business unit
tags
Innovative fifteen-year agreement ensures Humber River Regional Hospital is always at the leading edge of technology in many critical areas.
MISSISSAUGA, ON -- OCTOBER 15, 2012 --- Toronto's Humber River Regional Hospital (HRRH) and GE Healthcare are pleased to announce an innovative fifteen-year agreement that will implement the first Managed Equipment Services (MES) solution in North America. An MES agreement is a flexible and tailored technology and service agreement to provide long term, sustainable access to innovative medical equipment and services.